Table 2. Clinical significance of MST4... | Rockefeller University Press

Table 2.

Clinical significance of MST4 expression in GC

Groups	MST4 expression				n	Positive (%)	P value (Fisher’s test)
Groups	−	+	+ +	+ + +	n	Positive (%)	P value (Fisher’s test)
Sex
Male	19	25	8	13	65	70.8	0.6598
Female	9	7	4	3	23	60.9	0.6598
Age
<60 yr	6	10	3	10	29	79.3	0.1394
≥60 yr	22	22	9	6	59	62.7	0.1394
Tumor size
pT1 + pT2	1	1	3	7	12	91.7	0.0003***
pT3 + pT4	27	31	9	9	76	64.5	0.0003***
Lymph node metastasis
N0 + N1	4	8	10	14	36	88.9	0.0001***
N2 + N3	24	24	2	2	52	53.8	0.0001***
Distant metastasis
M0	25	32	12	16	85	70.6	0.0837
M1	3	0	0	0	3	0.0	0.0837
Tumor stage
I + II	9	8	8	12	37	75.7	0.0246*
III + IV	19	24	4	4	51	62.7	0.0246*
Total	28	32	12	16	88

Groups	MST4 expression				n	Positive (%)	P value (Fisher’s test)
Groups	−	+	+ +	+ + +	n	Positive (%)	P value (Fisher’s test)
Sex
Male	19	25	8	13	65	70.8	0.6598
Female	9	7	4	3	23	60.9	0.6598
Age
<60 yr	6	10	3	10	29	79.3	0.1394
≥60 yr	22	22	9	6	59	62.7	0.1394
Tumor size
pT1 + pT2	1	1	3	7	12	91.7	0.0003***
pT3 + pT4	27	31	9	9	76	64.5	0.0003***
Lymph node metastasis
N0 + N1	4	8	10	14	36	88.9	0.0001***
N2 + N3	24	24	2	2	52	53.8	0.0001***
Distant metastasis
M0	25	32	12	16	85	70.6	0.0837
M1	3	0	0	0	3	0.0	0.0837
Tumor stage
I + II	9	8	8	12	37	75.7	0.0246*
III + IV	19	24	4	4	51	62.7	0.0246*
Total	28	32	12	16	88

Asterisks indicate statistical significance. *, P < 0.05; ***, P < 0.001.